Clinical trials sponsored by Sunshine Lake Pharma Co., Ltd.
4
Recruiting trials
8
Conditions studied
Phase breakdown
Phase 1 3Phase 2 1Phase 3 1
Conditions studied
| Condition | Trials |
|---|---|
| Depression | 1 |
| Depressive Disorder, Major | 1 |
| HBV Infection | 1 |
| Healthy Subjects | 1 |
| Hepatitis B | 1 |
| NASH | 1 |
| Non - Alcoholic Steatohepatitis | 1 |
| Obesity | 1 |
Recruiting trials led by Sunshine Lake Pharma Co., Ltd.
- A Phase I Clinical Trial to Evaluate HECN30227 Injection in Healthy Subjects and Subjects With Chronic Hepatitis B
- A Safety, Tolerability, Pharmacokinetics/Pharmacodynamics Study of HEC169584 Capsules in Healthy Subjects
- A Study to Evaluate the Safety, Tolerability, PK/PD of HEC-007 Injection in Healthy and Overweight/Obese Subjects
- The Efficacy And Safety Of Mitizodone Phosphate Tablets In The Treatment of Patient With Major Depressive Disorder
Common questions
How many trials is Sunshine Lake Pharma Co., Ltd. recruiting for?
Sunshine Lake Pharma Co., Ltd. is the lead sponsor of 4 recruiting trials.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.